Mr. C.K. Cheung reports
EGF THERAMED COMMENTS ON TRADING HALT AND CONFIRMS SHARE CONSOLIDATION AND TRADING ON A POST CONSOLIDATED BASIS
Further to the trading halt issued by Investment Industry Regulatory Organization of Canada (IIROC) earlier this morning, EGF Theramed Health Corp. asks all shareholders to confirm their holdings with their financial advisers prior to executing any trades as the company has as of today undergone a share consolidation of its issued and outstanding common shares on a 100-old-to-one-new basis. No fractional common shares will be issued pursuant to the consolidation. All fractional interests of less than a whole share will be rounded down to the nearest whole number of shares. For example, if a shareholder was holding 100,000 shares in their account on Oct. 23, 2019, their account would reflect 1,000 shares on Oct. 24, 2019.
The shares are to be trading on a postconsolidated basis under the same symbol TMED on the Canadian Securities Exchange effective Oct. 24, 2019. The company also confirms that it has received a new ISIN and CUSIP for its postconsolidated symbol and new operating name of EGF Theramed Health Corp. The new ISIN is CA2684691033 and the new CUSIP is 268469103.
The company continues to develop products, technologies and diagnostic tools focused on personalized medical care including research with hemp-derived cannabidiol. The products will serve with the overall goal of improving health and elevating the human condition.
About EGF Theramed Health Corp.
Theramed is a technology company focused in the health care and life sciences sector to develop a personalized health care system.
We seek Safe Harbor.
© 2021 Canjex Publishing Ltd. All rights reserved.